Newsletter Subscribe

Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Eyenovia’s Redwood City Facility Clears FDA Inspection

Eyenovia announced the successful completion of the FDA inspection for its facility in Redwood City, California, marking a significant milestone in the company’s manufacturing capabilities. This achievement signals the green light for the facility to engage in final assembly, packaging,…

WashU Granted $20M for Eye Disease Screening Device

Washington University in St. Louis has been granted up to $20 million by the Advanced Research Projects Agency for Health (ARPA-H) to spearhead the development of a novel portable device aimed at revolutionizing the detection of eye diseases. The initiative,…

Novel Protocol to Rapidly Diagnose Eye Stroke

Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai (NYEE) have pioneered a novel protocol aimed at swiftly diagnosing eye stroke and expediting care to prevent irreversible vision loss. Published in Ophthalmology, their study outlines the use of…

Oculus, Mainline Instruments Forge UK, Ireland Distribution Pact

In a move signaling a strategic expansion, Mainline Instruments and Oculus Optikgeräte have announced the extension of their successful partnership into the ophthalmology sector for the UK and Ireland markets. This collaboration aims to introduce cutting-edge ophthalmic solutions, catering to…

Lighting and Activity in Elderly with Vision Impairment

A recent study published online in JAMA Ophthalmology sheds light on the significant impact of home environment, particularly lighting, on the activity levels of older adults with visual impairment. Conducted by Seema Banerjee, Ph.D., and colleagues from Johns Hopkins University,…

2023 Recap: Top 10 Acquisitions in the Ophthalmic Industry

In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…

Meridian Medical Introduces Ophthalmic Laser Line in US

Meridian Medical, headquartered in Switzerland, announced the launch of its line of ophthalmic lasers in the United States, following a series of FDA approvals. The FDA approval, received on January 25, includes the MR Q family of lasers, which offer…

Nicox and Kowa Strike Deal for NCX 470 in Japan

Nicox SA announced an agreement with Kowa, granting the latter exclusive rights in Japan for the development and commercialization of NCX 470, a promising nitric oxide (NO)-donating bimatoprost eye drop designed for reducing intraocular pressure (IOP) in individuals with glaucoma…

Stay informed and not overwhelmed, subscribe now!